
ANZCHOG ASM Pre-conference Workshops
Join us for one of our popular pre-conference workshops, held on Day 1 of the 2025 ANZCHOG ASM in Brisbane on Wednesday, 30 July.

Join us for one of our popular pre-conference workshops, held on Day 1 of the 2025 ANZCHOG ASM in Brisbane on Wednesday, 30 July.

Great news this week with the funding announcement for CoACT-Brain Cancer (The Consortium for Australian Children’s Trials in Brain Cancer), a national clinical trial consortium dedicated to improving outcomes for

A new funding partnership unites six leading philanthropic organisations to support the ambitious TarGeT trial, a cutting-edge international study that uses precision medicine to deliver treatments tailored to each patient’s

A paper by our Central Nervous System (CNS) Tumour Group was recently published in the Medical Journal of Australia!
This team effort by the group highlights the essential role

ANZCHOG advocates for funding and better outcomes for childhood cancer in Canberra

We talk to RCD Foundation about their partnership with ANZCHOG

Thanks to the Kids with Cancer Foundation and The Robert Connor Dawes Foundation for supporting ANZCHOG to sponsor the Deflexifol® at Relapse Trial (DART).
Thanks to support from the Australian Government and The Kids’ Cancer Project, an important trial investigating a treatment protocol for infants with leukaemia will soon be opened in Australia.

The expansion of ZERO, a precision medicine program for children with cancer, was announced on February 15th at The Royal Children’s Hospital in Melbourne.